| NCT05701774 | Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-01-31 | 2028-06 | 2028-06 |
| NCT05532020 | An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities | UNKNOWN | PHASE2 | 2023-01 | 2024-03 | 2024-01 |
| NCT04086810 | An Open-Label Study of DCCR Tablet in Patients With PWS | WITHDRAWN | PHASE3 | 2019-10 | 2019-10 | 2019-10 |
| NCT03714373 | Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period | COMPLETED | PHASE3 | 2018-10-01 | 2023-08-17 | 2023-08-17 |
| NCT03440814 | A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome | COMPLETED | PHASE3 | 2018-05-09 | 2020-05-01 | 2020-05-01 |